Smooth muscle antibodies and type 1 autoimmune hepatitis.

PubWeight™: 0.91‹?›

🔗 View Article (PMID 12765475)

Published in Autoimmunity on December 01, 2002

Authors

Paolo Muratori1, Luigi Muratori, Daniela Agostinelli, Georgios Pappas, Lorenza Veronesi, Alessandro Granito, Fabio Cassani, Paolo Terlizzi, Marco Lenzi, Francesco B Bianchi

Author Affiliations

1: Department of Internal Medicine, Cardioangiology, Hepatology, Alma Mater Studiorum, University of Bologna, Bologna, Italy.

Articles by these authors

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology (2003) 9.36

Comparison of PubMed, Scopus, Web of Science, and Google Scholar: strengths and weaknesses. FASEB J (2007) 7.45

The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology (2007) 6.68

Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology (2008) 6.35

Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis. Nat Genet (2010) 3.15

Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis. Am J Gastroenterol (2003) 2.69

Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations. PLoS Med (2007) 2.58

Antiendomysial and antihuman recombinant tissue transglutaminase antibodies in the diagnosis of coeliac disease: a biopsy-proven European multicentre study. Eur J Gastroenterol Hepatol (2005) 2.49

Bacterial infection-related morbidity and mortality in cirrhosis. Am J Gastroenterol (2007) 2.35

Yttrium-90 radioembolization vs sorafenib for intermediate-locally advanced hepatocellular carcinoma: a cohort study with propensity score analysis. Liver Int (2014) 2.23

Clinical impact of non-organ-specific autoantibodies on the response to combined antiviral treatment in patients with hepatitis C. Clin Infect Dis (2005) 1.83

Deamidated gliadin peptide antibodies as a routine test for celiac disease: a prospective analysis. J Clin Gastroenterol (2010) 1.70

The serological profile of the autoimmune hepatitis/primary biliary cirrhosis overlap syndrome. Am J Gastroenterol (2009) 1.70

Non-organ-specific autoantibodies in children with chronic hepatitis C: clinical significance and impact on interferon treatment. Clin Infect Dis (2003) 1.65

STING Millennium: A web-based suite of programs for comprehensive and simultaneous analysis of protein structure and sequence. Nucleic Acids Res (2003) 1.64

Detection of Ebola virus in oral fluid specimens during outbreaks of Ebola virus hemorrhagic fever in the Republic of Congo. Clin Infect Dis (2006) 1.62

Worldwide prevalence of head lice. Emerg Infect Dis (2008) 1.58

Patterns of appearance and risk of misdiagnosis of intrahepatic cholangiocarcinoma in cirrhosis at contrast enhanced ultrasound. Liver Int (2013) 1.57

Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group. J Hepatol (2004) 1.57

Thyroid autoimmunity in chronic idiopathic urticaria: implications for therapy. Am J Clin Dermatol (2002) 1.56

It's all in the face: amiodarone-induced myxedema and skin pigmentation. Eur J Dermatol (2006) 1.47

New global map of Crohn's disease: Genetic, environmental, and socioeconomic correlations. Inflamm Bowel Dis (2008) 1.45

Performance of the preliminary classification criteria for cryoglobulinaemic vasculitis and clinical manifestations in hepatitis C virus-unrelated cryoglobulinaemic vasculitis. Clin Exp Rheumatol (2012) 1.41

Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: a multicenter study of 664 patients and 1992 healthy controls. Hepatology (2008) 1.40

Sequential presentation of primary biliary cirrhosis and autoimmune hepatitis. Eur J Gastroenterol Hepatol (2014) 1.40

Non-organ-specific autoantibodies in nonalcoholic fatty liver disease: prevalence and correlates. Dig Dis Sci (2003) 1.37

An eternal microbe: Brucella DNA load persists for years after clinical cure. Clin Infect Dis (2008) 1.29

Celiac disease in autoimmune cholestatic liver disorders. Am J Gastroenterol (2002) 1.23

VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: the ALICE-1 study. Int J Cancer (2014) 1.11

A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis. Hepatology (2010) 1.10

Diversity of soil fungal communities of Cerrado and its closely surrounding agriculture fields. Arch Microbiol (2008) 1.10

Bacterial community associated with healthy and diseased reef coral Mussismilia hispida from eastern Brazil. Microb Ecol (2010) 1.10

Usefulness of antibodies to deamidated gliadin peptides in celiac disease diagnosis and follow-up. Dig Dis Sci (2008) 1.08

A "One Health" surveillance and control of brucellosis in developing countries: moving away from improvisation. Comp Immunol Microbiol Infect Dis (2012) 1.07

Infection-related morbidity and mortality in patients with connective tissue diseases: a systematic review. Clin Rheumatol (2006) 1.06

Treatment challenges and investigational opportunities in autoimmune hepatitis. Hepatology (2005) 1.02

Global transcriptome analysis of two wild relatives of peanut under drought and fungi infection. BMC Genomics (2012) 1.01

The liver in brucellosis. Clin Gastroenterol Hepatol (2007) 1.00

Antimitochondrial antibodies and other antibodies in primary biliary cirrhosis: diagnostic and prognostic value. Clin Liver Dis (2008) 1.00

Epidemiologic, clinical characteristics, and risk factors for adverse outcome in multiresistant gram-negative primary bacteremia of critically ill patients. Am J Infect Control (2010) 1.00

Cell-mediated immunity in human brucellosis. Microbes Infect (2010) 0.99

Brucellosis in infant after familial outbreak. Emerg Infect Dis (2008) 0.96

Susceptibility to thyroid disorders in hepatitis C. Clin Gastroenterol Hepatol (2005) 0.96

Genetic distinctions between autoimmune hepatitis in Italy and North America. World J Gastroenterol (2005) 0.95

Cytochrome P4502D6(193-212): a new immunodominant epitope and target of virus/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease. J Immunol (2003) 0.95

Sera of patients with celiac disease and neurologic disorders evoke a mitochondrial-dependent apoptosis in vitro. Gastroenterology (2007) 0.95

Virulence factors in brucellosis: implications for aetiopathogenesis and treatment. Expert Rev Mol Med (2007) 0.93

PML nuclear body component Sp140 is a novel autoantigen in primary biliary cirrhosis. Am J Gastroenterol (2009) 0.93

Treatment of hepatocellular carcinoma in Child-Pugh B patients. Dig Liver Dis (2013) 0.92

Detection of the M30 neoepitope as a new tool to quantify liver apoptosis: timing and patterns of positivity on frozen and paraffin-embedded sections. Am J Clin Pathol (2004) 0.91

Subacute thyroiditis in the course of novel H1N1 influenza infection. Endocrine (2010) 0.90

Hepatitis C virus infection associated with liver-kidney microsomal antibody type 1 (LKM1) autoantibodies in children. J Pediatr (2003) 0.89

Use of ceftriaxone in patients with severe leptospirosis. Int J Antimicrob Agents (2006) 0.88

The generation challenge programme platform: semantic standards and workbench for crop science. Int J Plant Genomics (2008) 0.87

Treatment of brucellosis. BMJ (2008) 0.87

Autoimmune hepatitis/primary biliary cirrhosis overlap syndrome and associated extrahepatic autoimmune diseases. Eur J Gastroenterol Hepatol (2012) 0.86

Efficacy and safety of peginterferon alfa-2b plus ribavirin for HCV-positive mixed cryoglobulinemia: a multicentre open-label study. Clin Exp Rheumatol (2011) 0.86

High prevalence of non-organ-specific autoantibodies in hepatitis C virus-infected cirrhotic patients from southern Italy. Dig Dis Sci (2003) 0.85

Autoimmune hepatitis in Italy: the Bologna experience. J Hepatol (2009) 0.85

Antinuclear antibodies as ancillary markers in primary biliary cirrhosis. Expert Rev Mol Diagn (2012) 0.85